Posts Tagged ‘mechanisms of action’

Prader-Willi Reminds Us GLP-1 Is Not the Whole Story of Obesity

June 17, 2025 — While much of the public has focused on the remarkable effects of GLP-1 agonists for many people living with obesity, an even more remarkable story has largely escaped notice. In March, FDA approved the first ever treatment for Prader-Willi syndrome. This drug, an extended-release form of diazoxide choline, is transforming the lives of families of […]

Three Men Tasting Wine

Good Taste in Treatment for Obesity – Biologically

June 4, 2024 — New research at the annual Endocrine Society meeting in Boston suggests that semaglutide treatment may work in part through enhancement of taste sensitivity in persons with obesity – especially sensitivity to the sweetness of foods. Mojca Jensterle Sever presented the results. She explained: “Some studies have reported that individuals living with obesity often perceive tastes […]